NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Clarification on Trifecta's Relationship with Eli Lilly and LillyDirect
TL;DR
Trifecta clarifies no partnership with Eli Lilly, maintaining independence to choose the best pharmacy providers for optimal patient value and care quality.
Trifecta issued a formal correction stating it has no contractual relationships with Eli Lilly or LillyDirect and maintains pharmacy selection based on care quality.
Trifecta ensures patient-centered care free from manufacturer influence, prioritizing evidence-based weight-loss services that benefit individual health outcomes.
Trifecta publicly corrected false partnership claims with Eli Lilly, reaffirming its commitment to unbiased, evidence-based weight management programs.
Found this article helpful?
Share it with your network and spread the knowledge!
This is a correction and clarification from Trifecta Med Spa, Trifecta Health, and Edward Fruitman, M.D. stating they do not have any relationship or partnership with Eli Lilly or LillyDirect.
Trifecta Med Spa, Trifecta Health, and Edward Fruitman, M.D. (collectively referred to as "Trifecta") are issuing this clarification regarding Eli Lilly and LillyDirect.
Trifecta does not have any contractual relationship, partnership, agreement, affiliation, or cooperation arrangement of any kind with Eli Lilly, LillyDirect, or any Eli Lilly subsidiary.
No, Trifecta does not endorse, promote, or show preference for any Eli Lilly products, including Zepbound, in their medical or weight-loss services.
This clarification ensures patients understand that Trifecta provides evidence-based, patient-centered care free of any manufacturer or pharmacy influence, allowing them to work with any licensed pharmacy that offers the best quality and value.
No, Trifecta has not entered - nor does it plan to enter - into any exclusive pharmacy arrangement, product preference policy, or partnership with Eli Lilly or LillyDirect.
Trifecta will continue to cooperate with any licensed pharmacy or pharmacy service provider that can offer the best quality of care, value, and pricing for its patients.
For more information, visit https://trifectamedspanyc.com/weight-management-program
This correction was issued on November 20, 2025, to address recent statements circulating online.
Curated from 24-7 Press Release
